Bio-Rad Laboratories, Inc. Class B

BIO.BNYSEUSD
278.25 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
279.00
NaN (NaN%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
279.00
NaN (NaN%)
🟢Market: OPEN
Open?$278.30
High?$278.30
Low?$278.25
Prev. Close?$278.25
Volume?151
Avg. Volume?112
VWAP?$280.84
Rel. Volume?1.35x
Bid / Ask
Bid?$233.39 × 40
Ask?$2,147.48 × 40
Spread?$1,914.09
Midpoint?$1,190.44
Valuation & Ratios
Market Cap?7.5B
Shares Out?5.1M
Float?511.2K
Float %?10.1%
P/E Ratio?9.88
P/B Ratio?1.01
EPS?$28.15
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.62Strong
Quick Ratio?4.19Strong
Cash Ratio?1.02Strong
Debt/Equity?0.16Low
ValuationFAIRLY VALUED
Score
78/100
P/E?
9.9CHEAP
P/B?
1.01CHEAP
P/S?
2.91CHEAP
P/FCF?
20.1FAIR
EV/EBITDA?
37.2HIGH
EV/Sales?
3.17FAIR
Returns & Efficiency
ROE?
10.2%FAIR
ROA?
7.2%STRONG
Cash Flow & Enterprise
FCF?$374.6M
Enterprise Value?$8.2B
Related Companies
Loading...
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
7.5B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1899-12-30
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000